VERITAS
Report
- Report Number
- 1416980-2018-06662
- Event Type
- Injury
- Date Received
- October 19, 2018
- Report Date
- December 4, 2018
- Manufacturer
- SYNOVIS SURGICAL INNOVATIONS
- Product Code
- FTM
- PMA / PMN Number
- NI
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- PHYSICIAN
Narratives
PATIENTS MEETING THE INCLUSION CRITERIA WERE OVER THE AGE OF 18. 2009 AND 2010. (B)(6). MEHRDAD, MARK, M., MEININGER, MICHAEL S. AND LACEY, MARTIN S. ¿VERITAS BOVINE PERICARDIUM FOR IMMEDIATE BREAST RECONSTRUCTION:A XENOGRAFT ALTERNATIVE TO ACELLULAR DERMAL MATRIX PRODUCTS¿. EUR J PLAST SURG, DOI 10.1007/S00238-012-0736-9 (APR-MAY 2012).
THE DEVICE WAS NOT RETURNED AND THE LOT NUMBER IS UNKNOWN; THEREFORE, A DEVICE ANALYSIS COULD NOT BE COMPLETED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
IT WAS REPORTED THAT OVER A 24-MONTH PERIOD 54 PATIENTS UNDERWENT 93 IMMEDIATE BREAST RECONSTRUCTIVE PROCEDURES FOLLOWING A STANDARDIZED TECHNIQUE WHERE VERITAS AS A PECTORAL EXPANDER WAS USED. FOLLOWING SURGERY WHERE VERITAS MATRIX WAS UTILIZED, SEVEN EVENTS OF SEROMA AND SIX SURGICAL SITE INFECTIONS WERE EXPERIENCED. PROPHYLACTIC INTRAVENOUS ANTIBIOTIC USE AND INTRAOPERATIVE ANTIBIOTIC IRRIGATION WITH BACITRACIN SOLUTION FOR TISSUE EXPANDERS AND IMPLANTS WAS RECORDED FOR ALL PATIENTS. AN UNREPORTED NUMBER OF PATIENT REQUIRED INPATIENT HOSPITALIZATION AND/OR IMPLANT REMOVAL FOR MAJOR INFECTIONS AND AN UNREPORTED NUMBER OF PATIENTS WITH MINOR INFECTIONS REQUIRED OUTPATIENT ORAL ANTIBIOTIC TREATMENT. AT THE TIME OF THIS REPORT, THE PATIENT OUTCOMES WERE NOT REPORTED. NO ADDITIONAL INFORMATION IS AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 826810 | VERITAS | MESH, SURGICAL | FTM | SYNOVIS SURGICAL INNOVATIONS | NA | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization| R |